Reaction
Synovial Fluid Analysis reporting signals
As of the last recalculation, Synovial Fluid Analysis appears in 86 FAERS reports alongside 28 co-occurring drug terms. The strongest observed disproportionality signal is METHYLPREDNISOLONE ACETATE (PRR 9,815.6).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Methylprednisolone Acetate | 68 | 9,815.6 | 9,900.2 |
| Sulfasalazine | 79 | 2,991.0 | 2,994.0 |
| Azathioprine | 79 | 2,654.9 | 2,657.3 |
| Trimethoprim | 44 | 1,848.8 | 1,855.7 |
| Tofacitinib | 79 | 1,262.0 | 1,262.6 |
| Tofacitinib Citrate | 36 | 1,142.3 | 1,145.5 |
| Amitriptyline Hydrochloride | 42 | 1,131.5 | 1,134.2 |
| Meloxicam | 64 | 1,039.4 | 1,040.5 |
| Naproxen | 65 | 817.1 | 817.8 |
| Hydroxychloroquine Sulfate | 67 | 802.1 | 802.7 |
| Esomeprazole Magnesium Capsule, Delayed Release | 25 | 587.5 | 588.5 |
| Esomeprazole Magnesium Delayed Release Capsules | 25 | 587.5 | 588.5 |
| Esomeprazole Magnesium Dihydrate | 25 | 584.9 | 586.0 |
| Adalimumab-Fkjp | 46 | 515.6 | 516.1 |
| Adalimumab-Aaty | 46 | 504.6 | 505.1 |
| Adalimumab-Adaz | 47 | 474.1 | 474.6 |
| Naproxen Sodium Tablet, Coated | 19 | 435.6 | 436.2 |
| Naproxen Sodium, Coated Tablets | 19 | 435.6 | 436.2 |
| Naproxen Sodium 220Mg | 19 | 435.0 | 435.6 |
| Dexlansoprazole | 36 | 358.6 | 358.9 |
| Ranitidine | 62 | 267.8 | 267.9 |
| Golimumab | 37 | 182.5 | 182.6 |
| Oxycodone And Acetaminophen Tablets | 8 | 179.0 | 179.1 |
| Ranitidine Hydrochloride | 25 | 156.5 | 156.6 |
| Certolizumab Pegol | 39 | 146.5 | 146.6 |
| Diclofenac Potassium, Film Coated | 3 | 89.4 | 89.4 |
| Diclofenac Potassium Tablets | 3 | 89.3 | 89.3 |
| Cortisone Acetate | 4 | 82.2 | 82.2 |